Covered recipient · General Payments record
DAVID B DAY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,727.91
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.97 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $98.04 | 5 |
| Mylan Specialty L.P. | $57.30 | 3 |
| Lilly USA, LLC | $35.85 | 2 |
| DEXCOM, INC. | $27.54 | 2 |
| Xeris Pharmaceuticals, Inc. | $26.73 | 2 |
| PFIZER INC. | $18.55 | 1 |
| Sumitomo Pharma America, Inc. | $16.82 | 1 |
| Supernus Pharmaceuticals, Inc. | $16.73 | 1 |
| Acerta Pharma LLC | $14.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $23.13 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115557927 | CMS |
| Amgen Inc. | $18.55 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115557937 | CMS |
| Amgen Inc. | $21.60 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115557947 | CMS |
| Amgen Inc. | $16.37 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115557958 | CMS |
| Amgen Inc. | $18.39 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115557966 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.41 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104463672 | CMS |
| Dexcom, Inc. | $13.47 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153356917 | CMS |
| Dexcom, Inc. | $14.07 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153356919 | CMS |
| Lilly USA, LLC | $17.05 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135625859 | CMS |
| Lilly USA, LLC | $18.80 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135602361 | CMS |
| Mylan Specialty L.P. | $18.78 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147327987 | CMS |
| Mylan Specialty L.P. | $17.12 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147378944 | CMS |
| Mylan Specialty L.P. | $21.40 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147299528 | CMS |
| PFIZER INC. | $18.55 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131281108 | CMS |
| Sumitomo Pharma America, Inc. | $16.82 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148954860 | CMS |
| Supernus Pharmaceuticals, Inc. | $16.73 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147875289 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.17 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144624255 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.56 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144624257 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.